1985PubMedRequires access

Clavulanic acid-potentiated activity of amoxicillin against Bacteroides fragilis.

Indiveri Mc, Hirsh Dc

Open publisher page 5 citations

Abstract

Seventy-seven clinical isolates of Bacteroides fragilis from animal sources were examined for beta-lactamase production and resistance to amoxicillin. Sixty-five (84%) of the isolates produced detectable amounts of beta-lactamase. Concentrations of amoxicillin greater than 8 micrograms/ml were required to inhibit all but 13 (17%) of the isolates evaluated. Clavulanic acid, a beta-lactamase inhibitor, minimally inhibited growth of B fragilis when used alone. However, a synergistic effect was found when amoxicillin and clavulanic acid were used together against B fragilis. Ninety-nine percent of the isolates were inhibited by concentrations of 1 microgram of amoxicillin/ml in combination with 0.5 microgram of clavulanic acid/ml.

About this research paper

What this paper is about

Seventy-seven clinical isolates of Bacteroides fragilis from animal sources were examined for beta-lactamase production and resistance to amoxicillin. Sixty-five (84%) of the isolates produced detectable amounts of beta-lactamase. Concentrations of amoxicillin greater than 8 micrograms/ml were required to inhibit all but 13 (17%) of the isolates evaluated. Clavulanic acid, a beta-lactamase inhibitor, minimally inhibited growth of B fragilis when used alone. However, a synergistic effect was found when amoxicillin and clavulanic acid were used together against B fragilis. Ninety-nine percent of the isolates were inhibited by concentrations of 1 microgram of amoxicillin/ml in combination with 0.5 microgram of clavulanic acid/ml.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Seventy-seven clinical isolates of Bacteroides fragilis from animal sources were examined for beta-lactamase production and resistance to amoxicillin. Sixty-five (84%) of the isolates produced detectable amounts of beta-lactamase. Concentrations of amoxicillin greater than 8 micrograms/ml were required to inhibit all but 13 (17%) of the isolates evaluated. Clavulanic acid, a beta-lactamase inhibitor, minimally inhibited growth of B fragilis when used alone. However, a synergistic effect was found when amoxicillin and clavulanic acid were used together against B fragilis. Ninety-nine percent of the isolates were inhibited by concentrations of 1 microgram of amoxicillin/ml in combination with 0.5 microgram of clavulanic acid/ml.

Key concepts: Bacteroides fragilis, Clavulanic acid, Amoxicillin, Microgram, Microbiology, Amoxicillin/clavulanic acid, Bacteroidaceae, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Clavulanic acid-potentiated activity of amoxicillin against Bacteroides fragilis. — Research Paper | ScholarLens